Tulane scientist awarded grant to develop novel Lyme therapy
May 21, 2019
Geetha Parthasarathy, PhD, a research scientist at Tulane National Primate Research Center, received the 2019 Laure Woods Emerging Leader Award from the Bay Area Lyme Foundation, to be a catalyst for future research, particularly in the areas of Lyme diagnostics and novel therapies. She was awarded a $100,000 grant.
New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
May 21, 2019
Morphine and other opioid-based painkillers are very effective at treating pain initially, but studies have shown that the drugs can make patients more pain-sensitive, prolonging their discomfort and increasing their risks of developing chronic pain.
Tulane professor to help find better treatment for respiratory disease
May 14, 2019
Tulane professor wins grant to help find better treatment for respiratory disease.
Tulane PhD student wins regional Three Minute Thesis Competition
May 10, 2019
On Feb. 16, Tulane bioinnovation PhD student Samantha Kurtz was selected as the winner of the 2019 Three Minute Thesis Competition. She had three minutes to share her research on “More Than Just a Pastie,” which centers around her research on novel drug-delivery systems to treat early-stage breast cancer.
Tulane researcher honored for work on AI ethics
May 07, 2019
Tulane researcher Nicholas Mattei is honored for work on AI ethics.
Tulane alumni couple donates $5 million for Presidential Chair
May 07, 2019
Tulane has received a $5 million commitment for a Presidential Chair.
Tulane University awarded $6.1 million to study HIV, tuberculosis in infants
April 30, 2019
Tuberculosis, the world’s leading infectious disease killer, is also the leading cause of death in infants with HIV. Researchers at Tulane National Primate Research Center will use a new $6.1 million grant from the National Institutes of Health to better understand how the developing immune system responds to these two diseases so that doctors can improve outcomes for infants and children across the globe.
Study finds improved WIC food packages reduced obesity risk for children
April 23, 2019
Sweeping changes designed to make a major federal food assistance program more nutritious for low-income families were effective in reducing obesity risk for 4-year-olds who had been on the program since birth, according to a new study by researchers from Tulane University, the University of California, Los Angeles, and PHFE WIC.
Tulane anthropologist awarded Guggenheim Fellowship to study Amazon rainforests
April 10, 2019
Tulane University anthropology professor William Balée has been named a 2019 Guggenheim Fellow by the John Simon Guggenheim Memorial Foundation to document the historical ecology of the lower Amazon basin.
Immersion Days 2019 to feature keynote by Bill & Melinda Gates Medical Research Institute CEO
March 21, 2019
Tulane University has added a more diverse menu of science, an extra day of programming and a national headliner to this year’s Immersion Days, the university’s premier event showcasing its latest research discoveries to biotechnology firms, venture capitalists, foundations and potential collaborators.
Pregnancy disorder subject of new Tulane study
March 12, 2019
Pregnancy disorder is the subject of new Tulane study.
Study finds genetic risks associated with prostate cancer are underestimated
February 07, 2019
More than 17 percent of prostate cancer patients are born with genetic variants that can be associated with a higher risk for various cancers, according to a new study in JAMA Oncology by researchers from Tulane University School of Medicine and genetics firm Invitae.
Study: Lower-carbon diets aren’t just good for the planet, they’re also healthier
January 24, 2019
A new Tulane University study examining the carbon footprint of what more than 16,000 Americans eat in a day has good news for environmentally conscious consumers— diets that are more climate-friendly are also healthier.
New drug shows promise against deadly ricin toxin
January 15, 2019
A new study at the Tulane National Primate Research Center showed for the first time that an experimental drug can save nonhuman primates exposed to deadly ricin toxin, a potential bioterrorism agent.